{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:44:45Z","timestamp":1791189885972,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.peptides.2005.04.004","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:52:41Z","timestamp":1131007961000},"page":"2339-2343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["CSF hypocretin-1\/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH)"],"prefix":"10.1016","volume":"26","author":[{"given":"K.","family":"Dohi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ripley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ohtaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Aruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2005.04.004_bib1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/WNL.37.10.1586","article-title":"Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the cooperative aneurysm study","volume":"37","author":"Adams","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.peptides.2005.04.004_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0196-9781(00)00369-7","article-title":"Immunoreactive orexin-A in human plasma","volume":"22","author":"Arihara","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2005.04.004_bib3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/01.STR.25.7.1342","article-title":"Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage","volume":"25","author":"Broderick","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2005.04.004_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2005.04.004_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00001756-200104170-00026","article-title":"Changes in CSF hypocretin-1 (orexin A) levels in rats across 24h and in response to food deprivation","volume":"12","author":"Fujiki","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2005.04.004_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3171\/jns.1968.28.1.0014","article-title":"Surgical risk as related to time of intervention in the repair of intracranial aneurysms","volume":"28","author":"Hunt","year":"1968","journal-title":"J Neurosurg"},{"key":"10.1016\/j.peptides.2005.04.004_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-3019(96)00370-9","article-title":"What are the actual incidence and mortality rates of subarachnoid hemorrhage?","volume":"47","author":"Inagawa","year":"1997","journal-title":"Surg Neurol"},{"key":"10.1016\/j.peptides.2005.04.004_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(02)00176-3","article-title":"Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat","volume":"324","author":"Irving","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2005.04.004_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1531-8249(200101)49:1<136::AID-ANA25>3.0.CO;2-M","article-title":"Hypocretin deficiency in familial symptomatic narcolepsy","volume":"49","author":"Melberg","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.peptides.2005.04.004_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2005.04.004_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.peptides.2005.04.004_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-3223(03)00349-4","article-title":"The hypocretin\/orexin system in health and disease","volume":"54","author":"Nishino","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.peptides.2005.04.004_bib13","first-page":"444","article-title":"Cortical blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage: three-dimensional N-isopropyl-p-[(123)I]iodoamphetamine single photon emission CT findings","volume":"24","author":"Ohkuma","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.peptides.2005.04.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.09.032","article-title":"Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation","volume":"995","author":"Pedrazzoli","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2005.04.004_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.peptides.2005.04.004_bib16","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.peptides.2005.04.004_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.peptides.2005.04.004_bib18","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/WNL.56.12.1751","article-title":"Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke","volume":"56","author":"Scammell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.peptides.2005.04.004_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3171\/jns.1986.64.4.0594","article-title":"Cerebral vasospasm evaluated by transcranial ultrasound correlated with clinical grade and CT-visualized subarachnoid hemorrhage","volume":"64","author":"Seiler","year":"1986","journal-title":"J Neurosurg"},{"key":"10.1016\/j.peptides.2005.04.004_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.neuro.24.1.429","article-title":"To eat or to sleep? Orexin in the regulation of feeding and wakefulness","volume":"24","author":"Willie","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.peptides.2005.04.004_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.0953-816x.2001.01725.x","article-title":"Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities","volume":"14","author":"Yoshida","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"8","key":"10.1016\/j.peptides.2005.04.004_bib22","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","article-title":"Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness","volume":"23","author":"Zeitzer","year":"2003","journal-title":"J Neurosci"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:18:29Z","timestamp":1759310309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978105001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0196978105001737"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2005.04.004","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF hypocretin-1\/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH)","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2005.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}